OIEJX
Price
$24.45
Change
-$0.15 (-0.61%)
Updated
Dec 17 closing price
RMFCX
Price
$55.64
Change
-$3.00 (-5.12%)
Updated
Dec 17 closing price
Ad is loading...

OIEJX vs RMFCX

Header iconOIEJX vs RMFCX Comparison
Open Charts OIEJX vs RMFCXBanner chart's image
JPMorgan Equity Income R6
Price$24.45
Change-$0.15 (-0.61%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$55.64
Change-$3.00 (-5.12%)
VolumeN/A
CapitalizationN/A
OIEJX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
OIEJX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OIEJX is a Sell and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 104B vs. OIEJX (45.3B). OIEJX pays higher dividends than RMFCX: OIEJX (2.12) vs RMFCX (1.69). OIEJX was incepted earlier than RMFCX: OIEJX (13 years) vs RMFCX (23 years). RMFCX is a more actively managed with annual turnover of: 25.00 vs. OIEJX (8.00). RMFCX has a lower initial minimum investment than OIEJX: RMFCX (250) vs OIEJX (15000000). RMFCX annual gain was more profitable for investors over the last year : 12.63 vs. OIEJX (9.47). RMFCX return over 5 years is better than : 40.39 vs. OIEJX (37.81).
OIEJXRMFCXOIEJX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years23 years-
Gain YTD8.47111.42374%
Front LoadN/AN/A-
Min. Initial Investment150000002506,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets45.3B104B44%
Annual Yield % from dividends2.121.69125%
Returns for 1 year9.4712.6375%
Returns for 3 years10.2114.1672%
Returns for 5 years37.8140.3994%
Returns for 10 years98.7061.84160%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc